Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Multiple Myeloma 38Lymphoma, Large B-Cell, Diffuse 37Burkitt Lymphoma 34Lymphoma 30Leukemia, Myeloid, Acute 30Lymphoma, Non-Hodgkin 29Recurrence 27Breast Neoplasms 27Neoplasms 23Lymphoma, B-Cell 23Leukemia, Lymphocytic, Chronic, B-Cell 22Myelodysplastic Syndromes 21Lymphoma, Follicular 21Hodgkin Disease 18Triple Negative Breast Neoplasms 17Leukemia 17Ovarian Neoplasms 16Melanoma 16Hematologic Neoplasms 15Neuroblastoma 14Lymphoma, Mantle-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Neoplasm Metastasis 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Biphenotypic, Acute 10Sarcoma 9Osteosarcoma 9

Interventions

peginterferon alfa-2b 1liposomal doxorubicin 1dolutegravir 1belinostat 1Zidovudine 1Tenofovir 1Taxes 1Paclitaxel 1Lomustine 1Irinotecan 1Introns 1Gemcitabine 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia-Lymphoma, Adult T-Cell × Cyclophosphamide × 90 days × Clear all
NCT02737046 2026-03-10

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

University of Miami

Phase 2 Completed
15 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡